Coherus Oncology
CHRS
CHRS
128 hedge funds and large institutions have $79.9M invested in Coherus Oncology in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 42 increasing their positions, 32 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
27% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 22
44% less capital invested
Capital invested by funds: $143M → $79.9M (-$62.9M)
Holders
128
Holding in Top 10
–
Calls
$78K
Puts
$69K
Top Buyers
| 1 | +$1.35M | |
| 2 | +$936K | |
| 3 | +$832K | |
| 4 |
Los Angeles Capital Management
Los Angeles,
California
|
+$749K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$737K |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$1.45M | |
| 3 | -$779K | |
| 4 |
Morgan Stanley
New York
|
-$759K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$727K |